Emergency rooms join fight against HIV: new study tests PrEP access
NCT ID NCT05588193
First seen Mar 18, 2026 · Last updated May 24, 2026 · Updated 10 times
Summary
This study tests two simple ways to help emergency room patients who are at risk for HIV get PrEP, a daily pill that prevents HIV. About 1,560 adults visiting the ER for sexual health concerns will be offered either a low-burden strategy to start PrEP right away or usual care. The goal is to see which approach gets more people on PrEP within three months, helping reduce HIV rates in communities hit hardest by the epidemic.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City University of New York - Hunter College
New York, New York, 10031, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
Conditions
Explore the condition pages connected to this study.